PRESS OFFICE
LISTING
Homenewsabout usContact UsWebsite
Welcome to the
Cipla Press Office
Cipla is a global pharmaceutical company whose goal is ensuring no patient shall be denied access to high quality & affordable medicine and support.
Follow us:
 

Latest news

The Cipla Foundation contributes to the vaccine rollout through partnership
Collaboration is the key to achieving population immunity
 2 Aug 2021 Read more

Wear your sassiest mismatched socks to support our healthcare workersDuring these unprecedented times, our healthcare workers have shown that superheroes don't always wear capes. 7 Jun 2021 Read more

Bronki Boosters: Turning children with asthma into superheroesAccording to the 2018 Global Asthma Report, asthma is the most common chronic illness in South African children and has shown an increasing prevalence in both urban and rural areas. Second-hand smoke exposure and living in highly populated areas can exacerbate asthma in young children. 8 Apr 2021 Read more

Access and affordability: South African launch of critical medications drives equitable accessIn putting healthcare in South Africa under the microscope, Covid-19 has exposed many weaknesses inherent in the country's fractured socio-economic environment. Yet, even before the pandemic reached our shores, equitable access to healthcare posed a significant obstacle for South Africa - a side effect of a tumultuous past. 2 Feb 2021 Read more

Cipla launches affordable tetanus vaccine to prevent tetanus deathsWhile the world remains focused on containing the spread of Covid-19, this should not avert our attention away from the ongoing battle to eradicate the many other diseases that can affect the quality of life for millions of South Africans. 8 Dec 2020 Read more


More news...

Contact Cipla

Email: az.oc.alpic@ofni
Tel: +27 21 943 4200
Customer Care: 080 222 6662
Website: www.cipla.co.za